Survival in patients with HR+/HER2- metastatic breast cancer treated with initial endocrine therapy versus initial chemotherapy. A French population-based study

Survival in patients with HR+/HER2- metastatic breast cancer treated with initial endocrine therapy versus initial chemotherapy. A French population-based study. Simon, Julien; Chaix, Marie; Billa, Oumar; Kamga, Ariane Mamguem; Roignot, Patrick; Ladoire, Sylvain; Coutant, Charles; Arveux, Patrick; Quantin, Catherine; Dabakuyo-Yonli, Tienhan Sandrine. British Journal of Cancer. 2020; 123: p.1071-1077. doi:10.1038/s41416-020-0979-3
Article